[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TR200002078T2 - Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. - Google Patents

Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.

Info

Publication number
TR200002078T2
TR200002078T2 TR2000/02078T TR200002078T TR200002078T2 TR 200002078 T2 TR200002078 T2 TR 200002078T2 TR 2000/02078 T TR2000/02078 T TR 2000/02078T TR 200002078 T TR200002078 T TR 200002078T TR 200002078 T2 TR200002078 T2 TR 200002078T2
Authority
TR
Turkey
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
synthetic polysaccharides
polysaccharides
Prior art date
Application number
TR2000/02078T
Other languages
English (en)
Inventor
Basten Johannes
Dreef-Tromp Cornelia
Driguez Pierre-Alexandre
Duchaussoy Philippe
Herbert Jean-Marc
Petitou Maurice
Van Boeckel Constant
Original Assignee
Sanofi-Synthelabo
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo, Akzo Nobel N.V. filed Critical Sanofi-Synthelabo
Publication of TR200002078T2 publication Critical patent/TR200002078T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut bulus asidik formdaki sentetik polisakkarid ve bunun farmasötik olarak kabul edilebilen tuzlari olup, bahsedilen polisakkaridin anyonik formu istem 1'de tanimlanan formül (I) ila (V)'ten birine karsilik gelmektedir. Bahsedilen polisakkaridler koagulasyon düzensizliklerine bagli hastaliklarin tedavisinde kullanilabilmektedir.
TR2000/02078T 1998-01-19 1999-01-13 Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. TR200002078T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9800515A FR2773804B1 (fr) 1998-01-19 1998-01-19 Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant

Publications (1)

Publication Number Publication Date
TR200002078T2 true TR200002078T2 (tr) 2000-11-21

Family

ID=9521914

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02078T TR200002078T2 (tr) 1998-01-19 1999-01-13 Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.

Country Status (41)

Country Link
US (1) US6528497B1 (tr)
EP (1) EP1049721B1 (tr)
JP (1) JP4402835B2 (tr)
KR (1) KR100513196B1 (tr)
CN (1) CN1165550C (tr)
AR (1) AR013019A1 (tr)
AT (1) ATE209219T1 (tr)
AU (1) AU741748B2 (tr)
BR (1) BRPI9907025B8 (tr)
CA (1) CA2317465C (tr)
CO (1) CO4970795A1 (tr)
CZ (1) CZ297815B6 (tr)
DE (1) DE69900718T2 (tr)
DK (1) DK1049721T3 (tr)
DZ (1) DZ2709A1 (tr)
EE (1) EE04157B1 (tr)
EG (1) EG23982A (tr)
ES (1) ES2168000T3 (tr)
FR (1) FR2773804B1 (tr)
GT (1) GT199900003A (tr)
HK (1) HK1030002A1 (tr)
HR (1) HRP20000480B1 (tr)
HU (1) HU228333B1 (tr)
IL (1) IL137241A0 (tr)
MA (1) MA26597A1 (tr)
MY (1) MY119090A (tr)
NO (1) NO329903B1 (tr)
NZ (1) NZ505492A (tr)
PE (1) PE20000269A1 (tr)
PL (1) PL202802B1 (tr)
PT (1) PT1049721E (tr)
RU (1) RU2211224C2 (tr)
SA (1) SA99191113B1 (tr)
SI (1) SI1049721T1 (tr)
SK (1) SK283411B6 (tr)
TR (1) TR200002078T2 (tr)
TW (1) TW548279B (tr)
UA (1) UA60352C2 (tr)
UY (1) UY25356A1 (tr)
WO (1) WO1999036443A1 (tr)
ZA (1) ZA99355B (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
IL188647A0 (en) 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
WO2009130704A1 (en) * 2008-04-24 2009-10-29 Technion Research And Development Foundation Ltd. Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
FR2935386B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
AU2010234779A1 (en) * 2009-03-30 2011-10-20 University Of Georgia Research Foundation, Inc. Heparan sulfate synthesis
NZ597326A (en) 2009-07-09 2013-05-31 Oshadi Drug Administration Ltd Matrix carrier compositions, methods and uses
EP2464668B1 (en) 2009-07-31 2022-12-07 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
JP2013537181A (ja) 2010-09-10 2013-09-30 サノフイ 抗血栓活性及び改善された代謝安定性を有するビオチン化多糖類
US9005664B2 (en) 2010-10-17 2015-04-14 Technion Research And Development Foundation Ltd. Denatured lactoglobulin and polyphenol coassemblies
FR2970969B1 (fr) 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260933A (en) * 1993-07-16 1996-07-26 Hercules Inc Cation-complexed polysaccharides; use in foods and pharmaceuticals
FR2749849B1 (fr) * 1996-06-14 1998-09-04 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
CZ427499A3 (cs) * 1998-05-29 2000-05-17 The Procter & Gamble Company Jemné topické antimikrobiální přípravky

Also Published As

Publication number Publication date
PT1049721E (pt) 2002-05-31
ATE209219T1 (de) 2001-12-15
NZ505492A (en) 2001-12-21
HRP20000480B1 (en) 2002-04-30
JP4402835B2 (ja) 2010-01-20
MA26597A1 (fr) 2004-12-20
HUP0102009A3 (en) 2003-07-28
CZ20002635A3 (cs) 2000-12-13
UY25356A1 (es) 2000-10-31
BR9907025B1 (pt) 2013-12-10
HU228333B1 (en) 2013-03-28
HRP20000480A2 (en) 2000-12-31
AU1974599A (en) 1999-08-02
KR100513196B1 (ko) 2005-09-07
FR2773804A1 (fr) 1999-07-23
HUP0102009A1 (hu) 2001-11-28
SI1049721T1 (en) 2002-06-30
ZA99355B (en) 2000-10-11
DE69900718D1 (de) 2002-02-21
KR20010034189A (ko) 2001-04-25
BR9907025A (pt) 2000-10-17
JP2002509164A (ja) 2002-03-26
UA60352C2 (uk) 2003-10-15
EE200000429A1 (et) 2003-06-16
SA99191113B1 (ar) 2006-10-11
US6528497B1 (en) 2003-03-04
EP1049721B1 (fr) 2001-11-21
DE69900718T2 (de) 2002-08-22
NO329903B1 (no) 2011-01-24
CO4970795A1 (es) 2000-11-07
MY119090A (en) 2005-03-31
AU741748B2 (en) 2001-12-06
NO20003662L (no) 2000-09-14
RU2211224C2 (ru) 2003-08-27
PL341875A1 (en) 2001-05-07
BRPI9907025B8 (pt) 2016-09-13
EP1049721A1 (fr) 2000-11-08
IL137241A0 (en) 2001-07-24
CZ297815B6 (cs) 2007-04-04
FR2773804B1 (fr) 2000-02-18
HK1030002A1 (en) 2001-04-20
GT199900003A (es) 2000-07-07
DK1049721T3 (da) 2002-04-02
CA2317465A1 (en) 1999-07-22
PL202802B1 (pl) 2009-07-31
DZ2709A1 (fr) 2003-09-01
EE04157B1 (et) 2003-10-15
AR013019A1 (es) 2000-11-22
SK10782000A3 (sk) 2001-02-12
CN1288470A (zh) 2001-03-21
EG23982A (en) 2008-02-27
NO20003662D0 (no) 2000-07-17
CN1165550C (zh) 2004-09-08
PE20000269A1 (es) 2000-06-15
CA2317465C (en) 2008-05-20
WO1999036443A1 (fr) 1999-07-22
SK283411B6 (sk) 2003-07-01
EE200000429A (et) 2001-12-17
TW548279B (en) 2003-08-21
ES2168000T3 (es) 2002-05-16

Similar Documents

Publication Publication Date Title
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
ES2163530T3 (es) Aplicacion de superoxido dismutasa (sod) en liposomas.
ES8500738A1 (es) Un procedimiento para la preparacion de una composicion antiinflamatoria topica como unguento en forma de gel
BR9813811A (pt) "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo"
PT1227820E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
HUP9903906A2 (hu) Kelátképző clioquinol felhasználása Alzheimer-kór kezelésére alkalmas gyógyszerkészítmények előállításánál
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
BG101118A (en) Therapeutical compounds
BR9809117A (pt) Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada
DE69914084D1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
DK1167354T3 (da) Racemisk huperzin A
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
DE69713300D1 (de) Benzopyran derivate mit leukotrien-antagonistischer wirkung
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
MD522G2 (ro) Noi derivaţi de piperidinii tioindol, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizare a lor ca analgezice
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
GEP20032968B (en) Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
YU107692A (sh) Sulfonamidi i postupak za njihovo dobijanje
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására